Similar articles

• Sulfonamide and penicillin resistance of group A hemolytic streptococci.

  RANTZ LA, RANDALL E, et al. RANTZ LA, et al. Proc Soc Exp Biol Med. 1946 May;62:54-7. doi: 10.3181/00379727-62-15370. Proc Soc Exp Biol Med. 1946. PMID: 20987567 No abstract available.
• In vitro development of temporary penicillin resistance in Streptococcus pyogenes.

  WEINSTEIN L, TSAO CC. WEINSTEIN L, et al. Proc Soc Exp Biol Med. 1947 Dec;66(3):598-602. doi: 10.3181/00379727-66-16170. Proc Soc Exp Biol Med. 1947. PMID: 18900038 No abstract available.
• THE THERAPEUTIC ACTIVITY OF PENICILLINS F, G, K, AND X IN EXPERIMENTAL INFECTIONS WITH PNEUMOCOCCUS TYPE I AND STREPTOCOCCUS PYOGENES.

  Eagle H; Technical Assistance of Arlyne D. Musselman. Eagle H, et al. J Exp Med. 1947 Jan 31;85(2):175-86. doi: 10.1084/jem.85.2.175. J Exp Med. 1947. PMID: 19871606 Free PMC article.
• Overcoming penicillin failures in the treatment of Group A streptococcal pharyngo-tonsillitis.

  Brook I. Brook I. Int J Pediatr Otorhinolaryngol. 2007 Oct;71(10):1501-8. doi: 10.1016/j.ijporl.2007.06.006. Epub 2007 Jul 17. Int J Pediatr Otorhinolaryngol. 2007. PMID: 17644191 Review.
• [Analysis of clinically isolated epidemic clone of group B streptococci with reduced penicillin susceptibility, PRGBS].

  Kimura K. Kimura K. Jpn J Antibiot. 2011 Dec;64(6):395-405. Jpn J Antibiot. 2011. PMID: 22686010 Review. Japanese. No abstract available.